Annual Conference
Now Open! Call for Abstracts for the General Poster Session
NCCN welcomes original abstracts from investigators in general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.
The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, October 29, 2025, 11:59 PM ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2025.
Save the Date
NCCN 2026 Annual Conference
Friday, March 27 – Sunday, March 29, 2026
Caribe Royale Orlando, Orlando, FL
Continuing Education
View a plenary session on Artificial Intelligence in Cancer Care: Opportunities, Challenges, and Governance.
Recorded Presentations
Experts from leading cancer centers came together to discuss updates to the NCCN Guidelines®, the latest in advances across several cancer types, and emerging issues in oncology.
Explore the recorded sessions and earn CE credit!
NCCN Annual Conference
Recorded presentations from the 2025 NCCN Annual Conference are now available on the NCCN Continuing Education Portal.
View NowNursing Program: Advancing Oncology Nursing™
Recorded presentations from the 2025 Nursing Program: Advancing Oncology Nursing™ are available on the NCCN Continuing Education portal.
View NowNCCN 2025 Oncology Fellows Program: New Horizons in Quality Cancer Care™
Recorded presentations from the NCCN 2025 Oncology Fellows Program: New Horizons in Quality Cancer Care™ are available on the NCCN Continuing Education portal.
View NowSupported by educational grants from:
- AstraZeneca
- BeiGene
- Coherus BioSciences
- Eisai, Inc.
- Exact Sciences
- Ferring Pharmaceuticals
- Genentech, a member of the Roche Group
- Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- Lantheus
- Lilly
- Menarini-Stemline
- Novartis
- Novocure
- Pharmacosmos Therapeutics Inc.
- Puma Biotechnology
- Taiho Oncology, Inc.
Supported by independent medical education grants from:
- AbbVie
- ADC Therapeutics
- Boehringer Ingelheim Pharmaceuticals, Inc.
- GSK
- Jazz Pharmaceuticals
- Rigel Pharmaceuticals, Inc.
Supported by independent educational grants from:
- Daiichi Sankyo
- Incyte Corporation
- Merck & Co., Inc., Rahway, NJ, USA
This activity is supported by funding from Blue Earth Diagnostics, A Bracco Company.
This educational activity is supported by a medical education grant from Exelixis, Inc.
This project has been made possible in part by a grant from Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program.
Conference Coverage
The 2025 NCCN Annual Conference was held Friday, March 28 – Sunday, March 30, 2025 at the Caribe Royale Orlando · Orlando, FL and virtually.
View Conference Summary and Other Press Coverage
Exhibit Hall
Conference attendees can view virtual exhibits in the Virtual Event Platform through June 2025.
For exhibitor opportunities, contact [email protected].
2025 Conference Sponsors
Platinum Level
Gold Level
Eisai Inc.
Johnson & Johnson
Regeneron
Bronze Level
AstraZeneca
BeOne Medicines
Geron Corporation
GSK
Jazz Pharmaceuticals
LeanTaaS
Servier Pharmaceuticals
Patient Advocacy Pavilion Sponsors
Emerald
AstraZeneca
BeOne Medicines
Coherus Biosciences
Eisai Inc.
Incyte Corporation
Johnson & Johnson
Servier Pharmaceuticals
Topaz
Important Alert About Fraudulent Sites
Information about this Conference may appear on fraudulent websites that appear to offer registration, exhibit space, and hotel rooms at discounted rates. These companies are in no way affiliated with NCCN. Please do not book any registrations or reservations through these sites, and register only through NCCN. If you have any questions or concerns, contact [email protected].